Amlin’s “Underperform” Rating Reaffirmed
Amlin — which operates a specialist Bermuda reinsurance underwriting platform — had its “underperform” rating reaffirmed by Credit Suisse in a research note issued on Monday [Apr. 15], Analyst Ratings Network reports.
They currently have a $5.92 price target on the stock.
A number of other firms have also recently commented on AML. Analysts at Westhouse Securities reiterated a “neutral” rating on shares of Amlin in a research note to investors on Tuesday, April 9. They now have a $6.98 price target on the stock.
Separately, analysts at Bank of America reiterated an “underperform” rating on shares of Amlin in a research note to investors on Monday, April 8. They now have a $5.91 price target on the stock.
Finally, analysts at Nomura reiterated a “neutral” rating on shares of Amlin in a research note to investors on Friday, April 5th. They now have a $7.10 price target on the stock.
Three research analysts have rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $6.62.
London-based Amlin plc is engaged in non-life insurance and reinsurance underwriting in the Lloyd’s market, Bermuda and Continental Europe.
